Skip to content

Multi-modal imaging for the evaluation of Long COVID-19

Multi-modal imaging for the evaluation of Long COVID-19

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067506
Enrollment
Unknown
Registered
2023-01-10
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Gold Standard:Nucleic acid detection method of COVID-19 Compared with 18F-FDG PET?FAPI PET?68Ga-DOTA-DX600 PET (Physiological distribution in healthy people) Complaint of sequelae (fatigue, cough, che
Index test:IgM?IgG (SARS-CoV-2)
Blood ACE2 levels
Using Siemens Biograph TruPoint 64 PET/CT and Biography mMR PET/MR to scan the head and trunk,the scanning range is 1 / 3 from the head to the upper thigh
Patients take a supine position and breathed calmly
The data are reconstructed by OSEM method to obtain coron

Sponsors

Luodian Hospital, Baoshan Distrit, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged 18-75 years, male and female unlimited; (2) Patients with Long COVID related symptoms(mainly involves RAAS system, nervous system, respiratory system) (3) Patient in good mental condition, who can cooperate with the examination process

Exclusion criteria

Exclusion criteria: (1) Patients who are skeptical about this trial and refuse to join this clinical study; (2) Patients with severe abnormal cardiovascular, liver and kidney function; (3) Pregnant and lactating women during pregnancy preparation; (4) Patients with claustrophobia or other mental diseases; (5) The investigators concluded that there are other reasons for inappropriate inclusion.

Design outcomes

Primary

MeasureTime frame
Standardized Uptake Value (SUV);SEN;ACC;SPE;AUC;

Countries

China

Contacts

Public ContactXiaolong Gao

Luodian Hospital, Baoshan Distrit, Shanghai

smalldragon1315@vip.sina.cn13916780898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026